Further investigations along this line are warranted in order to understand the role of MALAT1 in the development of the drug resistance phenotype in cancers and to identify potential combinatorial therapeutic opportunities to target MALAT1 to augment chemotherapeutic response. The gene discussed is MALAT1; the disease is cancer.